Our studies show that REDD1 deficiency engenders markedly elevated lipid uptake and storage, coupled to a glycolytic phenotype and activated FAO that sustains metabolic demands of the RAS mutant context to promote tumor progression including metastatic dissemination. Here, DDIT4 is linked to neoplasm.